Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bioreactor
Manufacturing
Lonza plots major mammalian production boost in Europe and U.S.
Lonza is plugging nearly $1 billion into a pair of new mammalian drug substance factories in Switzerland and New Hampshire.
Fraiser Kansteiner
May 6, 2021 8:49am
Taysha Gene Therapies draws up lease for first commercial plant
Dec 22, 2020 8:35am
U.K. manufacturer Abzena pumps $60M into San Diego plant
Oct 9, 2020 10:35am
Bionova aims to scale up commercial production at its HQ
Jul 16, 2020 10:35am
Fujifilm plots $928M infusion at Danish biologics plant
Jun 9, 2020 11:32am
Lithuanian CDMO adding biologics capacity, 60-plus jobs
Apr 17, 2019 10:40am